MSB 4.39% $1.09 mesoblast limited

Back pain stem cell injection, page-55

  1. 3,852 Posts.
    lightbulb Created with Sketch. 1303
    Sad fact, money gets short, budget gets slashed, reality of successful business.
    Funding trial costs seems to be the main problem. So instead of bashing MSB management, perhaps some suggestions on how to fund these trials.
    (1) Board of directors could fund a trial however they maybe saving there $$ to get us across the line on RA, CHF or LBP.
    That would be a great way to lift moral both with in the company and outside investors.
    (2) It has been suggested that shorts actively post negative sediments and continue to run MSB down and make huge profits in doing so. They could quite easily fund some. We could name the treatments after them.
    TREV CELL
    MAD CELL
    a partnership
    Trevmad Cell
    Madtrev Cell (sounds great)
    Or possibly after the company they may work for. That would seriously give them a good reason to continue there relentless work.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.050(4.39%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.14 $1.17 $1.07 $8.385M 7.489M

Buyers (Bids)

No. Vol. Price($)
1 8500 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 26954 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.